Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma

Safiya Khurshid, Akila S. Venkataramany, Matias Montes, John F. Kipp, Ryan D. Roberts, Nicolas Wein, Frank Rigo, Pin-Yi Wang, Timothy P. Cripe, Dawn S. Chandler · 2024

Read Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma by Safiya Khurshid, Akila S. Venkataramany, Matias Montes, John F. Kipp, Ryan D. Roberts, Nicolas Wein, Frank Rigo, Pin-Yi Wang, Timothy P. Cripe, Dawn S. Chandler (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11666956.txt.

Description

Safiya Khurshid and co-authors test gene-switch strands against a child bone cancer in a 2024 lab study. This cancer leans on growth signals through the insulin path, but blocking the main receiver failed in past trials. Cancer cells dodge by splicing their insulin receiver into a growth-hungry form.

The strands push splicing toward the calmer form, which curbed cancer traits and hardy growth in dishes. Packed into a virus, the strands lifted the calm form a bit. Paired with a receiver-blocking antibody drug, they slowed cancer growth more. The team says the pairing merits more work as a fresh route for patients.

Catalog record

CREATORSafiya Khurshid, Akila S. Venkataramany, Matias Montes, John F. Kipp, Ryan D. Roberts, Nicolas Wein, Frank Rigo, Pin-Yi Wang, Timothy P. Cripe, Dawn S. Chandler
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11666956

Browse the full library · About the Tower of Babel